Clinical Trials
2 trialsNCT00063219 2009-08-21
Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed
NCT00063427 2009-08-21
Study Evaluating MAC-321 in Colorectal Cancer
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed